Prevalence, Determinants, and Outcomes of Low Disease Activity and Remission Attainment in Patients With Systemic Lupus Erythematosus That Is Clinically Active.

Arthritis Care Res (Hoboken) · 2026 · PMC12975691 · PMID 40955714

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significanceP = 0.10so close (0.05 < p ≤ 0.1)

In addition, IS dose reduction was also associated with a shorter time to flare after LLDAS attainment (HR 1.27, 95% CI 1.02–1.60, P = 0.036) but did not reach statistical significance after DORIS attainment (HR 1.23, 95% CI 0.96–1.60, P = 0.10; Table 4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.